Inositol 1,4,5-trisphosphate receptor type 1 (IP3R1)

Inositol 1,4,5-trisphosphate receptor type 1 (IP3R1) is a large intracellular calcium channel predominantly located on the endoplasmic reticulum, where it mediates the release of Ca^2+^ into the cytosol upon binding the second messenger inositol 1,4,5-trisphosphate (IP3)[2][6][7][8]. IP3R1 is a tetrameric complex, each subunit containing specific domains for IP3 binding, calcium modulation, and channel gating. Its gating is regulated by IP3, intracellular Ca^2+^, ATP, and other modulators, enabling highly spatially and temporally dynamic calcium signaling in response to extracellular stimuli[4][6]. IP3R1 plays essential roles in signal transduction, cell fate decision (proliferation, apoptosis), neural function (learning, memory, motility), and is implicated in several diseases, especially those affecting the nervous system such as spinocerebellar ataxias, epilepsy, and some neurodegenerative and cardiovascular disorders[7]. Several natural and synthetic compounds interact with or modulate IP3R1 activity, making it an important pharmacological target and research focus for disorders of calcium signaling[5][8].

Other names

Inositol trisphosphate receptor type 1InsP3R1IP3 receptor 1Inositol 1,4,5-trisphosphate receptor 1p400 (historical, from initial cerebellum studies)

Agonists bind to the IP3-binding core, triggering channel opening and Ca^2+ release from the endoplasmic reticulum[2][7][8]. Antagonists or inhibitors block IP3 binding or stabilize closed channel conformations, preventing Ca^2+ release[8][5]. Allosteric modulators alter sensitivity or response to IP3[5].